Biomarkers for Prediction of Tumor Response to Radiotherapy
NCT03744819 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 100
Last updated 2024-02-06
Summary
This study aims to explore potential biomarkers for prediction of therapeutic outcomes in patients with solid tumors after radiotherapy
Conditions
Sponsors & Collaborators
-
University of Oxford
collaborator OTHER -
Chuangzhen Chen
lead OTHER
Principal Investigators
-
Chuangzhen Chen, MD · Affiliated Cancer Hospital of Shantou University Medical College
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-10-29
- Primary Completion
- 2025-11-30
- Completion
- 2026-11-30
Countries
- China
Study Locations
More Related Trials
-
The Risk Factors for Acute Radiation Pneumonitis in Patients With Prior Receipt of Immune Checkpoint Inhibitors
NCT05219851 ·Status: RECRUITING
-
Investigating the Tumour Immune Response of Radiotherapy
NCT05076500 ·Status: RECRUITING
-
Discovery of Biomarkers for Intrinsic Radiation Sensitivity in Cancer Patients
NCT04340024 ·Status: RECRUITING
-
Deep Learning-based Classification and Prediction of Radiation Dermatitis in Head and Neck Patients
NCT05607225 ·Status: UNKNOWN
-
Using Breath, Cell Free DNA and Image Analysis to PRedIct Normal TissUe and Tumour Response During Prostate Cancer SBRT
NCT04081428 ·Status: ACTIVE_NOT_RECRUITING
-
Hypofractionated vs. Conventionally Fractionated Concurrent CRT for LD-SCLC
NCT02688036 ·Status: UNKNOWN ·Phase: PHASE3
-
Stereotactic Radiotherapy With Different Fractionation Modes for the Early Lung Cancer
NCT05802641 ·Status: UNKNOWN
-
The Optimal Number of Fiducial Marker for Stereotactic Body Radiotherapy
NCT06342323 ·Status: RECRUITING
-
Markerless Image Guidance Using Intrafraction Kolovoltage X-ray Imaging for Lung Cancer Radiotherapy
NCT04310891 ·Status: ACTIVE_NOT_RECRUITING
-
Elimination of PTV Margins Based on Online Adaptive Stereotactic Radiotherapy for Centrally Located Early-stage Non-small Cell Lung Cancer
NCT06730295 ·Status: RECRUITING ·Phase: PHASE2
-
Displacement Distance and Stabilization Time for Liver Fiducial Marker
NCT05816837 ·Status: UNKNOWN
-
Target Volume Delineation After NACT in LA-NPCarcinoma Patients Treated With NACT+ CCRT
NCT03283293 ·Status: COMPLETED ·Phase: PHASE2
-
Study on the Biological Prediction Models of Radiation Pneumonitis
NCT02490319 ·Status: UNKNOWN
-
Role of SPECT in Radiotherapy of Lung Cancer and Toxicity Evaluation
NCT01745484 ·Status: COMPLETED ·Phase: NA
-
Delineation of Target Volume of Stereotactic Radiotherapy for Spinal Tumors
NCT06587022 ·Status: RECRUITING
-
Marker Guided Breathhold Radiotherapy in NSCLC
NCT02447900 ·Status: COMPLETED ·Phase: PHASE1
-
Multimodal Monitoring of Radiotherapy Response in Squamous Cell Cancer
NCT02379039 ·Status: COMPLETED
-
Safety and Efficacy of SBRT in the Treatment of Thoracic Malignant Tumors at Different Sites
NCT05349552 ·Status: RECRUITING
-
NBTXR3 Activated by Radiation Therapy for the Treatment of Locally Advanced or Borderline-Resectable Pancreatic Cancer
NCT04484909 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Radiation Pneumonitis After SBRT for NSCLC
NCT02428049 ·Status: ACTIVE_NOT_RECRUITING
-
Clinical Trial of Radiotherapy in Treating Primary Hepatocellular Carcinoma
NCT03614546 ·Status: UNKNOWN ·Phase: NA
-
Hyperbaric Oxygen in the Prevention of Radiation Pneumonitis
NCT05189496 ·Status: RECRUITING ·Phase: NA
-
A Study of Individualized Radiotherapy Based on a Prediction Model of Lymph Node Metastasis in Hepatocellular Carcinoma
NCT03416803 ·Status: UNKNOWN ·Phase: NA
-
Hyperpolarized 13C MRI as a Biomarker in Advanced Solid Tumors
NCT05599048 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Predictors of Radiation Pneumonitis in Locally Advanced Lung Cancer Treated With Chemoradiation
NCT01580579 ·Status: COMPLETED